These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14607625)

  • 41. Double point mutation in the core promoter region of hepatitis B virus (HBV) genotype C may be related to liver deterioration in patients with chronic HBV infection.
    Nakashima H; Furusyo N; Kubo N; Kashiwagi K; Etoh Y; Kashiwagi S; Hayashi J
    J Gastroenterol Hepatol; 2004 May; 19(5):541-50. PubMed ID: 15086598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of core promoter mutations in chronic hepatitis B.
    Xing L; Zhu C; Shi H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):163-5. PubMed ID: 11503052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
    Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM
    J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of basal core promoter and precore mutations in chronic hepatitis B.
    Ozgenc O; Ozacar T; Erensoy S; Inan N; Ari A; Kuruuzum Z; Bilgic A
    Hepatogastroenterology; 2007 Dec; 54(80):2319-23. PubMed ID: 18265656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variations in the functional domain of basal core promoter of hepatitis B virus among Eastern Indian patients with prevalence of genotypes A, C, and D among the same ethnic population.
    Biswas A; Banerjee A; Chandra PK; Datta S; Panigrahi R; Dutta D; De BK; Pal M; Guha SK; Chakrabarti S; Chakravarty R
    J Med Virol; 2011 Feb; 83(2):253-60. PubMed ID: 21181919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.
    Chen CH; Lee CM; Lu SN; Changchien CS; Wang JC; Wang JH; Hung CH; Hu TH
    J Hepatol; 2006 Jan; 44(1):76-82. PubMed ID: 16298013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
    J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mismatched PCR combined with restriction fragment length polymorphism assay for identification of hot spot for mutation in core promoter sequence of hepatitis B virus in Chinese isolates].
    Hou J; Cheng J; Wang Z
    Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):107-10. PubMed ID: 10923419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis.
    Liu CJ; Kao JH; Lai MY; Chen PJ; Chen DS
    J Med Virol; 2004 Apr; 72(4):545-50. PubMed ID: 14981756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phylogenetic, virological, and clinical characteristics of genotype C hepatitis B virus with TCC at codon 15 of the precore region.
    Chan HL; Tse CH; Ng EY; Leung KS; Lee KH; Tsui SK; Sung JJ
    J Clin Microbiol; 2006 Mar; 44(3):681-7. PubMed ID: 16517839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of HBV core promoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B.
    Kusumoto K; Yatsuhashi H; Nakao R; Hamada R; Fukuda M; Tamada Y; Taura N; Komori A; Daikoku M; Hamasaki K; Nakao K; Ishibashi H; Miyakawa Y; Eguchi K
    J Gastroenterol Hepatol; 2008 May; 23(5):790-3. PubMed ID: 18410611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia.
    Bahri O; Cheikh I; Hajji N; Djebbi A; Maamouri N; Sadraoui A; Mami NB; Triki H
    J Med Virol; 2006 Mar; 78(3):353-7. PubMed ID: 16419125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Relationship between Shenzhen HBV genotype and precore/core promoter mutation and antiviral effects].
    Yuan J; Zhou BP; Gong ZJ; Xu LM; Jiang XL; Mizokami M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):30-2. PubMed ID: 16642214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of core promoter and precore stop codon mutants of hepatitis B virus in Vietnam.
    Huy TT; Ushijima H; Quang VX; Ngoc TT; Hayashi S; Sata T; Abe K
    J Med Virol; 2004 Oct; 74(2):228-36. PubMed ID: 15332271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of HBV DNA sequences that are predictive of response to lamivudine therapy.
    Ciancio A; Smedile A; Rizzetto M; Lagget M; Gerin J; Korba B
    Hepatology; 2004 Jan; 39(1):64-73. PubMed ID: 14752824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis.
    Marrone A; Zampino R; Karayannis P; Cirillo G; Cesaro G; Guerrera B; Ricciotti R; del Giudice EM; Utili R; Adinolfi LE; Ruggiero G
    Aliment Pharmacol Ther; 2005 Oct; 22(8):707-14. PubMed ID: 16197491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter.
    Laras A; Koskinas J; Hadziyannis SJ
    Virology; 2002 Mar; 295(1):86-96. PubMed ID: 12033768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.
    Cheong JY; Cho SW; Yoo JH; Hong SP; Kim SO; Yoo WD; Kim JH
    Hepatogastroenterology; 2008; 55(84):1029-33. PubMed ID: 18705323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleotide mutations associated with hepatitis B e antigen negativity.
    Sun X; Rokuhara A; Tanaka E; Gad A; Mutou H; Matsumoto A; Yoshizawa K; Kiyosawa K
    J Med Virol; 2005 Jun; 76(2):170-5. PubMed ID: 15834874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.